StonvexLoading…
StonvexStonvexStonvexCore line items from RYAN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $782.90M | $2.99B | $2.26B | $1.52B |
Operating Income | $94.60M | $493.64M | $402.08M | $291.29M |
Net Income | $17.65M | $63.40M | $55.42M | $24.33M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $11.01B | $10.56B | $9.85B | $10.63B |
Total Liabilities | $9.79B | $9.31B | $8.62B | $9.44B |
Cash & Equivalents | $154.65M | $158.32M | $153.49M | $172.59M |
Free Cash Flow OCF − CapEx | $-180.68M | $575.71M | $329.74M | $174.21M |
Shares Outstanding | Not available | Not available | Not available | Not available |